Qingke Pingchuan Granule (清咳平喘颗粒) Combined with Tiotropium Bromide Inhalation Spray for Treatment of 40 Cases of Chronic Obstructive Pulmonary Disease of Stable Stage with Phlegm-heat Obstructing the Lung Pattern
|更新时间:2022-02-28
|
Qingke Pingchuan Granule (清咳平喘颗粒) Combined with Tiotropium Bromide Inhalation Spray for Treatment of 40 Cases of Chronic Obstructive Pulmonary Disease of Stable Stage with Phlegm-heat Obstructing the Lung Pattern
Journal of Traditional Chinese MedicineVol. 63, Issue 5, Pages: 455-460(2022)
YUAN Qing,MA Jiaju,LIU Xitong,et al.Qingke Pingchuan Granule (清咳平喘颗粒) Combined with Tiotropium Bromide Inhalation Spray for Treatment of 40 Cases of Chronic Obstructive Pulmonary Disease of Stable Stage with Phlegm-heat Obstructing the Lung Pattern[J].Journal of Traditional Chinese Medicine,2022,63(05):455-460.
YUAN Qing,MA Jiaju,LIU Xitong,et al.Qingke Pingchuan Granule (清咳平喘颗粒) Combined with Tiotropium Bromide Inhalation Spray for Treatment of 40 Cases of Chronic Obstructive Pulmonary Disease of Stable Stage with Phlegm-heat Obstructing the Lung Pattern[J].Journal of Traditional Chinese Medicine,2022,63(05):455-460.DOI: 10.13288/j.11-2166/r.2022.05.011.
Qingke Pingchuan Granule (清咳平喘颗粒) Combined with Tiotropium Bromide Inhalation Spray for Treatment of 40 Cases of Chronic Obstructive Pulmonary Disease of Stable Stage with Phlegm-heat Obstructing the Lung Pattern
(清咳平喘颗粒, QPG) combined with tiotropium bromide inhalation spray for the treatment of chronic obstructive pulmonary disease (COPD) of stable stage with phlegm-heat obstructing the lung pattern, and to explore the possible mechanism.
Methods
2
Eighty patients with stable COPD were randomly divided into intervention group and control group, with 40 patients in each group. The control group was treated with tiotropium bromide inhalation spray, 1 capsule each time, once daily; additionally, the intervention group was treated with QPG, 10 g each time, three times daily; the course of treatment was 8 weeks in both groups. The pulmonary function parameters such as maximum mid-expiratory flow (MMEF), forced expiratory volume in the first second (FEV1)/ forced vital capacity (FVC), and FEV1/FVC, the COPD assessment test (CAT) score, the airway mucus hypersecretion indexes such as cough, expectoration difficulty, daytime and night-time sputum volume and sputum properties, and the levels of serum tumor necrosis factor alpha (TNF-α), interleukin 17 (IL-17), and leukotriene B4 (LTB4) were assessed. The clinical effect was evaluated, and adverse reactions of both groups were recorded and compared.
Results
2
In terms of total effective rate, the intervention group (95%) was significantly higher than the control group (75%,
P=
0.025). MMEF, FEV1/FVC, FEV1 and FVC significantly increased after treatment in both groups (
P
<0.05), and more increases were seen in the intervention group than in the control group (
P
<0.05 or
P
<0.01). The airway mucus hypersecretion indexes, the CAT score, and the levels of serum TNF- α, IL-17 and LTB4 in both groups were significantly reduced after treatment (
P
<0.05), and more reductions were found in the intervention group (
P
<0.05 or
P
<0.01). There was one case of nausea and one case of flatulence in the intervention group, while one case of nausea occurred in the control group, all of which disappeared without treatment, and there was no significant difference between groups (
P
= 1.000).
Conclusion
2
QPG combined with tiotropium bromide inhalation spray has better effects than inhalation spray alone on improving lung function and relieving clinical symptoms in patients with stable COPD, which may be related to QPG's function of inhibiting airway mucus hypersecretion and down-regulating serum TNF-α, IL-17, and LTB4 levels.
关键词
Keywords
references
CHEN X , MAY B , DI YM , et al . Oral Chinese herbal medicine combined with pharmacotherapy for stabel COPD:a system revive medicine of effect on BODE index and six minute walk test [J]. PLoS One , 2014 , 9 ( 3 ): e91830 .
JONES PW , HARDING G , BERRY P , et al . Development and first validation of the COPD assessment test [J]. Eur Respir J , 2009 , 34 ( 3 ): 648 - 654 .
Global Initiative for Chronic Obstructive Lung Disease . Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease (2019 Report) [J]. Eur Respir J , 2019 , 53 ( 5 ) : 1900164 .
RAWFORD B , MONZ B , HOHLFELD J , et a1 . Development and validation of a cough and sputum assessment questionnaire [J]. Respir Med , 2008 , 102 ( 11 ): 1545 - 1555 .
MIRAVITLLS M , GUERRERO T , MAYURDOMO C , et al . Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO study group [J]. Respiration , 2000 , 67 ( 5 ): 495 - 501 .
VITENBERGA Z , PILMANE M , BABJONISEVA A . The evaluation of inflammatory, anti-inflammatory and regulatory factors contributing to the pathogenesis of COPD in airways [J]. Pathol Res Pract , 2019 , 215 ( 1 ): 97 - 105 .
Influencing Factors of the Effectiveness of Wenfei Guyuan Umbilical Moxibustion (温肺固元脐灸) for Stable Chronic Obstructive Pulmonary Disease Based on Multi-Model Fusion Analysis:a Retrospective Study
Clinical Observation on 45 Cases of Chronic Obstructive Pulmonary Disease in the Stable Phase with Qi Deficiency,Blood Stasis and Phlegm Obstruction Syndrome with Auxiliary Treated with Jinwei Guben Decoction (金卫固本汤) Combined with Bailing Capsule (百令胶囊)
“Earth-banking up to Generate Metal” Method in Chinese Herbal Medicine Combined with Conventional Therapy for Stable Chronic Obstructive Pulmonary Disease: Meta Analysis with GRADE Assessment
Effects of Bufei Granules on Quality of Life in Patients with Stable Chr onic Obstructive Pulmonary Disease
Medication and Prescription Rules of Chinese Medicine Treatment for Chronic Obstructive Pulmonary Disease at Stable Stage:A Literature Research of Recent 20 Years
Related Author
ZHAO Di
WANG Minghang
MENG Yuanyuan
WANG Gaoming
KONG Deyu
ZHENG Xudong
ZHOU Huimin
WANG Ruitao
Related Institution
The First Affiliated Hospital of Henan University of Chinese Medicine/National Regional Traditional Chinese Medicine (Pulmonary Diseases)Diagnosis and Treatment Centre
The First Clinical Medical College,Henan University of Chinese Medicine
Beijing University of Chinese Medicine Third Affiliated Hospital
Guangdong Province Traditional Chinese Medical Hospital/ The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine